For the Inventor, By the Inventor

Enter assignee name

San Francisco, CA, United States of America

Ubiome, Inc.

USPTO Granted Patents = 59

Trademarks = 5

Forward Citations = 365

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

Zachary Apte (59 out of 95 patents)

Jessica Richman (59 out of 95 patents)

Daniel Almonacid (56 out of 90 patents)

4. Siavosh Rezvan Behbahani (12 out of 26 patents)

5. Catalina Valdivia (6 out of 7 patents)

6. Rodrigo Ortiz (5 out of 10 patents)

7. Inti Pedroso (4 out of 6 patents)

8. Paz Tapia (4 out of 6 patents)

9. Victoria Dumas (3 out of 3 patents)

10. Eduardo Morales (3 out of 8 patents)

Core Competencies:

Microbiome

Diagnostics

Therapeutics

Neurological Health

Autoimmune Conditions

Cardiovascular Disease

Functional Features

Cutaneous Conditions

Locomotor System

Diet-Related Conditions

Mouth-Associated Conditions

Skin Related Conditions

59 patents: Sort by Forward Citations

1. 10415105 - Method and system for diagnostic testing (2019-09-17),

2. 10410749 - Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions (2019-09-10),

3. 10409955 - Method and system for microbiome-derived diagnostics and therapeutics for locomotor system conditions (2019-09-10),

4. 10388407 - Method and system for characterizing a headache-related condition (2019-08-20),

5. 10383519 - Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features (2019-08-20),

6. 10381117 - Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions (2019-08-13),

7. 10381112 - Method and system for characterizing allergy-related conditions associated with microorganisms (2019-08-13),

8. 10380325 - Method and system for microbiome-derived diagnostics and therapeutics (2019-08-13),

9. 10366793 - Method and system for characterizing microorganism-related conditions (2019-07-30),

10. 10366789 - Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues (2019-07-30),

11. 10366782 - Method and system for microbiome-derived characterization, diagnostics, and therapeutics for cardiovascular disease conditions (2019-07-30),

12. 10360348 - Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues (2019-07-23),

13. 10360347 - Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues (2019-07-23),

14. 10360346 - Method and system for microbiome-derived diagnostics (2019-07-23),

15. 10358682 - Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features (2019-07-23),

Ubiome, Inc. is a pioneering company based in San Francisco, specializing in microbiome diagnostics. The organization focuses on developing innovative solutions that leverage microbiome analysis to enhance understanding of health and disease. Their research spans various domains, including neurological health, autoimmune conditions, cardiovascular disease, and cutaneous conditions. By integrating advanced diagnostic technologies, Ubiome aims to provide insights that can lead to personalized therapeutic approaches and improved patient outcomes.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

59 Patents

#86 in San Francisco, CA

#1,424 in California

#6,068 in US

#12,219 in the World

San Francisco, CA, United States of America

Ubiome, Inc.

Forward Citations = 365

10 inventors:

Zachary Apte (59 out of 95 patents)

Jessica Richman (59 out of 95 patents)

Daniel Almonacid (56 out of 90 patents)

4. Siavosh Rezvan Behbahani (12 out of 26 patents)

5. Catalina Valdivia (6 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…